Oxfam America

FTAA & CAFTA

Intellectual Property and Access to Medicines
Recent free trade agreements include intellectual property provisions that extend generous patent rights to pharmaceutical companies, which can price life-saving drugs out of the reach of poor people.
FTAA: A Unique Challenge to Small Countries
"The current one-size-fits-all proposal simply ignores the special development needs of the smaller economies, which just cannot compete with heavily subsidized producers in the US." Simon Ticehurst, Oxfam's trade policy expert for this region